Workflow
Monthly information on share capital and company voting rights
GlobeNewswire· 2025-01-08 21:30
(Article 223-16 of General Regulation of the French financial markets authority)PARIS, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number of sharesin the capitalTotal number of votingrights12/31/2024100,093,87388,660,539 For further information on Cellectis, please contact: Media contact: Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93 Invest ...
Amesite Announces Closing of Public Offering
GlobeNewswire· 2025-01-08 21:30
DETROIT, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced the closing of its “best efforts” underwritten public offering of 1,201,667 shares of its common stock at a public offering price of $3.00 per share, before underwriting discounts and commissions, for an aggregate offering of approximately $3.6 million. Certain officers and directors of the Company participat ...
Encompass Health Announces Date of 2024 Fourth Quarter Earnings Call
Prnewswire· 2025-01-08 21:30
BIRMINGHAM, Ala., Jan. 8, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its fourth quarter ended Dec. 31, 2024, after the market closes on Thursday, Feb. 6, 2025. The Company will host an investor conference call at 10 a.m. ET on Friday, Feb. 7, 2025, to discuss its results. The conference call may be accessed by dialing 800-579-2543 and providing the conference ID EHCQ424. International callers should dial 785-424-1789 and provide the same conference ID. ...
DIAMONDROCK HOSPITALITY ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 EARNINGS RELEASE AND CONFERENCE CALL
Prnewswire· 2025-01-08 21:30
BETHESDA, Md., Jan. 8, 2025 /PRNewswire/ -- DiamondRock Hospitality Company (the "Company") (NYSE: DRH) will report financial results for the fourth quarter and full year 2024 after the market closes on Thursday, February 27, 2025. A conference call for investors and other interested parties is scheduled for the next day on Friday, February 28, 2025 at 10:00 a.m. Eastern Time (ET). The information to be discussed on the call will be contained in the Company's earnings release, which will be available in the ...
Blue Owl Capital Corporation and Blue Owl Capital Corporation III Announce Shareholder Approvals of Merger
Prnewswire· 2025-01-08 21:30
NEW YORK, Jan. 8, 2025 /PRNewswire/ -- Blue Owl Capital Corporation (NYSE: OBDC) and Blue Owl Capital Corporation III (NYSE: OBDE) today announced that each company obtained shareholder approval of all proposals related to the previously announced merger between the two companies at their respective shareholder meetings held today. Shareholders voted overwhelmingly in favor of the proposed transaction, with over 97% of OBDC votes cast and nearly 100% of OBDE votes cast, respectively, voting in favor of the ...
Orchid Island Capital Announces Estimated Fourth Quarter 2024 Results January 2025 Monthly Dividend and December 31, 2024 RMBS Portfolio Characteristics
Newsfilter· 2025-01-08 21:25
January 2025 Monthly Dividend of $0.12 Per Share of Common StockEstimated Book Value Per Share as of December 31, 2024 of $8.09Estimated GAAP net income of $0.07 per share for the quarter ended December 31, 2024, including an estimated $0.02 per share of net realized and unrealized gains on RMBS and derivative instruments    Estimated 0.6% total return on equity for the quarter ended December 31, 2024  Estimated book value, net income and total return on equity amounts are preliminary, subject to change, an ...
Orchid Island Capital Announces Estimated Fourth Quarter 2024 Results January 2025 Monthly Dividend and December 31, 2024 RMBS Portfolio Characteristics
GlobeNewswire· 2025-01-08 21:25
January 2025 Monthly Dividend of $0.12 Per Share of Common StockEstimated Book Value Per Share as of December 31, 2024 of $8.09Estimated GAAP net income of $0.07 per share for the quarter ended December 31, 2024, including an estimated $0.02 per share of net realized and unrealized gains on RMBS and derivative instruments Estimated 0.6% total return on equity for the quarter ended December 31, 2024 Estimated book value, net income and total return on equity amounts are preliminary, subject to change, and su ...
O-I GLASS ANNOUNCES FULL YEAR AND FOURTH QUARTER 2024 EARNINGS CONFERENCE CALL AND WEBCAST
Newsfilter· 2025-01-08 21:20
PERRYSBURG, Ohio, Jan. 08, 2025 (GLOBE NEWSWIRE) -- O-I Glass, Inc. (NYSE:OI) has scheduled its full year and fourth quarter 2024 conference call and webcast for Wednesday, February 5, 2025, at 8 a.m. EST. The Company's news release for the full year and fourth quarter 2024 earnings will be issued after the market closes on Tuesday, February 4. What:         O-I Conference Call and WebcastEarnings presentation materials will also be posted on the O-I website, www.o-i.com/investors, when the earnings news re ...
Grayscale Investments® Announces Rebalancing of Multi-Asset Funds for Fourth Quarter 2024
GlobeNewswire· 2025-01-08 21:15
STAMFORD, Conn., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Grayscale Investments®, an asset management firm with expertise in crypto investing, offering more than 25 crypto investment products, and manager of Grayscale® Decentralized AI Fund (AI Fund), Grayscale® Decentralized Finance (DeFi) Fund (OTCQB: DEFG) (DeFi Fund), Grayscale® Digital Large Cap Fund (OTCQX: GDLC) (Digital Large Cap Fund), and Grayscale® Smart Contract Platform Ex-Ethereum Fund (GSCPxE Fund), today announced the updated Fund Component weighti ...
Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch
GlobeNewswire· 2025-01-08 21:15
-- Approximately $50.0 million of net revenue from sales of LUMRYZ™ estimated for the fourth quarter, a greater than 150% increase over $19.5 million for the comparable period in 2023 -- --2,500 patients on LUMRYZ as of December 31, 2024, including 600 patients that initiated therapy in the fourth quarter -- -- LUMRYZ net product revenue of $240 – $260 million in 2025, representing 50% year-over-year growth at the midpoint -- -- Management to host a conference call today at 4:30 p.m. ET -- DUBLIN, Ireland, ...